The mannose-binding lectin pathway is a significant contributor to reperfusion injury in the type 2 diabetic heart

Diabetes and Vascular Disease Research

Volumn 6, Issue 3, 2009, Pages 172-180

  La Bonte, Laura R ^a,b   Dokken, Betsy ^a,b   Davis Gorman, Grace ^a,b   Stahl, Gregory L ^c   McDonagh, Paul F ^a,b,d  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Complement; Inflammation; Ischaemia reperfusion injury; Zucker diabetic fatty rat

Indexed keywords

COMPLEMENT COMPONENT C3; MANNOSE BINDING LECTIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY P2D5; NAFAMSTAT MESILATE; UNCLASSIFIED DRUG; COMPLEMENT INHIBITOR; GUANIDINE DERIVATIVE; INTERCELLULAR ADHESION MOLECULE 1; MANNOSE BINDING PROTEIN A; NAFAMSTAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; ISCHEMIC HEART DISEASE; MALE; NEUTROPHIL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOPHYSIOLOGY; RAT; REPERFUSION INJURY; ZUCKER DIABETIC FATTY RAT; ANIMAL; DISEASE MODEL; DOSE RESPONSE; DRUG ANTAGONISM; HEART INFARCTION; HEART MUSCLE; IMMUNOLOGY; METABOLISM; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; TIME; ZUCKER RAT;

ANIMALS; ANTIBODIES, MONOCLONAL; COMPLEMENT C3; COMPLEMENT INACTIVATING AGENTS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GUANIDINES; INTERCELLULAR ADHESION MOLECULE-1; MALE; MANNOSE-BINDING LECTIN; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NEUTROPHIL INFILTRATION; RATS; RATS, ZUCKER; TIME FACTORS;

EID: 77954600548     PISSN: 14791641     EISSN: 17528984     Source Type: Journal    
DOI: 10.1177/1479164109336051     Document Type: Article

References (55)

1. Zhang, L, Zalewsk,i A, Liu, Y (2003) Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries. Circulation 108: 472-8. (Pubitemid 36935542)
2. Stockklauser-Farber, K, Ballausen, T, Laufer, A, Rosen, P (2000) Influence of diabetes on cardiac nitric oxide synthase expression and activity. Biochim Biophys Acta 1535: 10-20.
3. Tuttle, HA, Davis-Gorman, G, Goldman, S, Copeland, JG, McDonagh, PF (2004) Proinflammatory cytokines are increased in type 2 diabetic women with cardiovascular disease. J Diabetes Complicat 18: 343-51. (Pubitemid 39505175)
4. Jordan, JE, Montalto, MC, Stahl, GL (2001) Inhibition of mannose-binding lectin reduces postischemic myocardial reperfusion injury. Circulation 104: 1413-8. (Pubitemid 32880155)
5. Collard, CD, Väkevä, A, Morrissey, MA, et al. (2000) Complement activation after oxidative stress. Role of the lectin complement pathway. Am J Pathol 156: 1549-56. (Pubitemid 30646694)
6. La Bonte, LR, Davis-Gorman, G, Stahl, GL, McDonagh, PF (2008) Complement inhibition reduces injury in the type 2 diabetic heart following ischaemia and reperfusion. Am J Physol Heart Circ Physiol 294: H1282-90. (Pubitemid 351468725)
7. Pinckard, RN, O'Rourke, RA, Crawford, MH, et al. (1980) Complement localization and mediation of ischemic injury in baboon myocardium. J Clin Invest 66: 1050-6. (Pubitemid 11233806)
8. Vakeva, A, Laurila, P, Meri, S (1992) Loss of expression of protectin (CD59) is associated with complement membrane attack complex deposition in myocardial infarction. Lab Invest 67: 608-16.
9. Hokama, JY, Ritter, LS, Davis-Gorman, G, Cimetta, AD, Copeland, JG, McDonagh, PF (2000) Diabetes enhances leukocyte accumulation in the coronary microcirculation early in reperfusion following ischaemia. J Diabetes Complicat 14: 96-107. (Pubitemid 30665760)
10. Ritter, LS, McDonagh, PF (1997) Low flow reperfusion after myocardial ischaemia enhances leukocyte accumulation in coronary microcirculation. Am J Physiol 273: H1154-65.
11. Tonnesen, MG, Anderson, DC, Springer, TA (1989) Adherence of neutrophils to cultured human microvascular endothelial cells. Stimulation by chemotactic peptides and lipid mediators and dependence upon the Mac-1, LFA-1, p150.95 glycoprotein family. J Clin Invest 83: 637-46. (Pubitemid 19061188)
12. Sacks, T, Moldow, CF, Craddock, PR, Bowers, TK, Jacob, HS (1978) Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes: An in vitro model of immune vascular damage. J Clin Invest 61: 1161-67. (Pubitemid 8324140)
13. Saddi, S, Holzknecht, RA, Patte, CP (2000) Endothelial cell activation by pore-forming structures: Pivotal role for Interleukin- 1á. Circulation 101: 1867-73. (Pubitemid 30213111)
14. Kilgore, KS, Flory, CM, Miller, BP (1996) The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells. Am J Pathol 149: 953-61. (Pubitemid 26334179)
15. Walsh, M, Bourcier, T, Takahashi, K, et al. (2005) Mannose binding lectin is a regulator of inflammation that accompanies myocardial ischaemia and reperfusion injury. J Immunol 175: 541-46. (Pubitemid 40884360)
16. Hansen, T, Tarnow, L, Thiel, S, et al. (2004) Association between mannose-binding lectin and vascular complications in type 1 diabetes. Diabetes 53: 1570-76. (Pubitemid 38697671)
17. Clark, JB, Palmer, CJ, Shaw, WN (1983) The diabetic Zucker Fatty Rat (41611). Proc Soc Exp Biol Med 173: 68-75. (Pubitemid 13088195)
18. Fujii, S, Hitomi, Y (1981) New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin. Biochim Biophys Acta 661: 342-45. (Pubitemid 12233442)
19. Ikari, N, Sakai, Y, Hitomi, Y, Fujii, S (1983) New synthetic inhibitor to the alternative complement pathway. Immunology 49: 685.
20. Walsh, MC, Shaffer, LA, Guikema, BJ, et al. (2007) Fluorochrome- linked immunoassay for functional analysis of the mannose binding lectin complement pathway to the level of C3 cleavage. J Immuno Methods 323: 147-59. (Pubitemid 46890966)
21. Pfeifer, PH, Kawahara, MS, Hugli, TE (1999) Possible mechanism for in vitro complement activation in blood and plasma samples: Futhan/EDTA controls in vitro complement activation. Clin Chem 45: 1190-99. (Pubitemid 29424257)
22. Homeister, JW, Satoh, P, Lucchesi, BR (1992) Effects of complement activation in the isolated heart. Role of the terminal complement components. Circ Res 71: 303-19.
23. Kubota, K, Mizoguchi, H, Miura, Y, Suda, T, Takaku, F (1980) A new technique for the cytochemical examination of human hemopoietic cells grown in agar gel. Exp Hematol 8: 339-44. (Pubitemid 10125293)
24. Lefer, AM, Weyrich, A, Buerke, M (1994) Role of selectins, a new family of adhesion molecules, in ischaemia-reperfusion injury. Cardiovasc Res 28: 289-94. (Pubitemid 24131064)
25. Vakeva, AP, Agah, A, Rollins, SA, Matis, LA, Li, L, Stahl, GL (1998) Myocardial infarction and apoptosis after myocardial ischaemia and reperfusion. Role of the terminal complement components and inhibition by anti-C5 therapy. Circulation 97: 2259-67. (Pubitemid 28265388)
26. American Heart Association. (2005) Heart disease and stroke statistics - 2005 update.
27. Kannel, WB, McGee, DL (1979) Diabetes and cardiovascular disease: The Framingham study. JAMA 241: 2035-38. (Pubitemid 9228506)
28. Østergaard, J, Hansen, TK, Thiel, S, Flyvbjerg, A (2005) Complement activation and diabetic vascular complications. Clin Chim Acta 361: 10-19. (Pubitemid 41382606)
29. Jerath, RS, Burek, CL, Hoffman, WH, Passmore, GG (2005) Complement activation in diabetic ketoacidosis and its treatment. Clin Immunol 116: 11-17. (Pubitemid 40733578)
30. Scantlebury, T, Sniderman, AD, Cianflone, K (2001) Regulation by retinoic acid of acylation-stimulating protein and complement C3 in human adipocytes. Biochem J 356: 445-52. (Pubitemid 32532355)
31. Scantlebury, T, Maslowska, M, Cianflone, K (1998) Chylomicron- specific enhancement of acylation stimulating protein and precursor protein C3 production in differentiated human adipocytes. J Biol Chem 273: 20903-09. (Pubitemid 28385370)
32. Muscari, A, Massarelli, G, Bastagli, L, et al. (2000) Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men. Eur Heart J 21: 1081-90. (Pubitemid 30352992)
33. Hansen, TK, Thiel, S, Wouters, PJ, Christiansen, JS, Van den Berghe, G (2003) Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 88: 1082-88. (Pubitemid 36337759)
34. Engstrom, G, Hedblad, B, Eriksson, KF, Janzon, L, Lindgarde, F (2005) Complement C3 is a risk factor for the development of diabetes: A population-based cohort study. Diabetes 54: 570-76.
35. McMillan, DE (1980) Elevation of complement components in diabetes mellitus. Diabetes Metab 6: 265-70. (Pubitemid 11189948)
36. Busche, MN, Walsh, MC, McMullen, ME, Guikema, BJ, Stahl, GL (2008) Mannose-binding lectin plays a critical role in myocardial ischaemia and reperfusion injury in a mouse model of diabetes. Diabetologia 51: 1544-51.
37. Henry, ML, Davidson, LB, Wilson, JE, et al. (2008) Whole blood aggregation and coagulation in db/db and ob/ob mouse models of type 2 diabetes. Blood Coagul Fibrinolysis 19: 124-34. (Pubitemid 351252990)
38. Paul, W, Queen, LR, Page, CP, Ferro, A (2007) Increased platelet aggregation in vivo in the Zucker Diabetic Fatty rat: Differences from the streptozotocin diabetic rat. Br J Pharmacol 150: 105-11. (Pubitemid 46094675)
39. Fiane, AE, Videm, V, Lingaas, PS, et al. (2003) Mechanism of complement activation and its role in the inflammatory response after thoracoabdominal aortic aneurysm repair. Circulation 108: 849-56. (Pubitemid 37022128)
40. Carden, DL, Granger, DN (2000) Pathophysiology of ischaemia- reperfusion injury. J Pathol 190: 255-66.
41. de Vries, B, Kohl, J, Leclercq, WKG, et al. (2003) Complement factor C5a mediates renal ischaemia-reperfusion injury independent from neutrophils. J Immunol 170: 3883-89. (Pubitemid 36359260)
42. Acosta, J, Hettinga, J, Flückiger, R, et al. (2000) Molecular basis for a link between complement and the vascular complications of diabetes. PNAS 97: 5450-55. (Pubitemid 30313739)
43. Ito, W, Schäfer, JJ, Bhakdi, S, et al. (1996) Influence of the terminal complement-complex on reperfusion injury, no-reflow and arrhythmias: A comparison between C6-competent and C6-deficient rabbits. Cardiovasc Res 32: 294-305. (Pubitemid 26246875)
44. Rossen, RD, Swain, JL, Michael, LH, Weakley, S, Giannini, E, Entman, ML (1985) Selective accumulation of the first component of complement and leukocytes in ischemic canine heart muscle. A possible initiator of an extra myocardial mechanism of ischemic injury. Circ Res 57: 119-30. (Pubitemid 15238848)
45. Dreyer, WJ, Michael, LH, West, S, et al. (1991) Neutrophil accumulation in ischemic canine myocardium. Insights into time course, distribution, and mechanism of localization during early reperfusion. Circulation 84: 400-11.
46. Akatsu, H, Abe, M, Miwa, T, et al. (2002) Distribution of rat C5a anaphylatoxin receptor. Microbiol Immunol 46: 863-74. (Pubitemid 36019161)
47. Zhang, H, Qin, G, Liang, G, Li, J, Barrington, RA, Liu, D (2007) C5aR-mediated myocardial ischaemia/reperfusion injury. Biochem Biophys Res Comm 357: 446-52.
48. Atsuumi, T, Yaoita, H, Shichishima, T, Maehara, K, Fujita, T, Maruyama, Y (2001) Complement and polymorphonuclear leukocyte activation each play a role in determining myocardial ischaemia-reperfusion injury. Jpn Circ J 65: 659-66.
49. Simpson, PJ, Todd III, RF, Fantone, JC, Mickelson, JR, Griffin, JD, Lucchesi, BR (1988) Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mol, Anti-CD11b) that inhibits leukocyte adhesion. J Clin Invest 81: 624-29. (Pubitemid 18075262)
50. McDonagh, PF, Hokama, JY, Copeland, JG, Reynolds, JM (1997) The blood contribution to early myocardial reperfusion injury is amplified in diabetes. Diabetes 46: 1859-67. (Pubitemid 27456422)
51. Ritter, LS, Orozco, JA, Coull, BM, McDonagh, PF (2000) Leukocyte accumulation and hemodynamic changes in the cerebral microcirculation during early reperfusion after stroke. Stroke 31: 1153-61. (Pubitemid 30253540)
52. Soriano, SG, Coxon, A, Wang, YF, et al. (1999) Mice deficient in Mac-1 (CD11b/CD18) are less susceptible to cerebral ischaemia/reperfusion injury. Stroke 30: 134-39. (Pubitemid 29029454)
53. Rinder, CS, Fontes, M, Mathew, JP, Rinder, HM, Smith, BR, Multicenter Study of Perioperative Ischaemia (McSPI) Research Group. (2003) Neutrophil CD11b upregulation during cardiopulmonary bypass is associated with postoperative renal injury. Ann Thorac Surg 75: 899-905. (Pubitemid 36298365)
54. Booth, G, Stalker, TJ, Lefer, AM, Scalia, R (2001) Elevated ambient glucose induces acute inflammatory events in the microvasculature: Effects of insulin. Am J Physiol Endocrinol Metab 280: E848-56.
55. Merin, M (2008) Global Health: Addressing the world's health challenges. Diabetes threatens lives worldwide. [Web Page]; http://www.america.gov/st/ health-english/2008/April/200804 10113749liameruoy0.5424921.html.